SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION
The prescribed route of administration for each Systemic Anti-Cancer Therapy Drug Administration in a Systemic Anti-Cancer Therapy Drug Cycle.
Format / Length
an2
Description
National Codes
| Code | Description |
|---|---|
| 01 | Intravenous |
| 02 | Oral |
| 03 | Intrathecal |
| 04 | Intramuscular |
| 05 | Subcutaneous |
| 06 | Intraarterial |
| 07 | Intraperitoneal |
| 08 | Other intracavity Intracavernous |
| 09 | Intravesical (Intra-Vesicular) |
| 10 | Intratumour / Intralesional (Retired 1 September 2019 ) |
| 11 | Cutaneous (Topical) |
| 12 | Intradermal |
| 13 | Intratumour |
| 14 | Intralesional |
| 98 | Other (not listed) |
| 99 | Other (Retired 1 September 2019 ) |
Also Known As
This Data Element is also known by these names:
| Context | Alias |
|---|---|
| Plural | SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTES OF ADMINISTRATION |
Where Used
| Type | Link | How used |
|---|---|---|
| Data Set | Systemic Anti-Cancer Therapy Data Set | references in description SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION |